CD8A and colorectal cancer: This result was reversed when the Song M’s study was excluded [17] and meta-analysis of these five trials indicated that SFI combined with chemotherapy in the treatment of colorectal cancer had an advantage of increasing the percentage of helper CD8+ compared with control group.